Vor bio to participate in the oppenheimer 34th annual healthcare life sciences conference

Cambridge, mass., feb. 07, 2024 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the oppenheimer 34th annual healthcare life sciences conference.
VOR Ratings Summary
VOR Quant Ranking